A 74% Profit Jump the Tape Ignored: Litigation Releases Flatter a Genuinely Good Quarter, and Bern Still Holds the Pen

Results vs. Consensus

Q3 2025 Scorecard

Year-Over-Year Comparisons

The composition of the revenue line matters more than its 3.5% growth rate. Net fee and commission income, the most durable and most highly valued revenue stream a wealth manager owns, grew 10.5% to $7,204m and now represents 56.5% of total revenues. Net interest income grew 10.4% despite a Swiss policy rate at zero, which is a genuine achievement of balance-sheet management rather than a rate windfall. Both of those lines went the right way. The offset was a 4.9% decline in fair-value trading income and a $268m fall in other income, the latter reflecting the absence of the $128m gain on the sale of the Credit Suisse Securities (China) stake booked a year ago.

The expense side is where the integration is visible. Operating expenses fell 4.4% year over year, but the composition is uneven: personnel expenses actually rose $283m, including a $165m increase in integration-related post-employment benefit costs plus higher financial-adviser compensation on higher compensable revenues and larger performance-award accruals. The entire decline came from general and administrative expenses, down $634m, of which $599m is the year-over-year swing in net litigation releases. Take that swing away and the operating expense base is essentially flat year over year while the cost programme continues to grind out savings underneath. This is a bank still carrying roughly $1.3bn a quarter of integration-related expense, which is precisely why reported earnings sit so far below underlying earnings.

Quarter-Over-Quarter Comparisons

The sequential comparison is the more flattering of the two, and it is also the more misleading. Net profit rose only 3.6% quarter over quarter despite a 29% jump in reported pre-tax profit, because the second quarter carried a negative 9.5% effective tax rate. Two consecutive quarters of abnormal tax outcomes make the sequential net-profit line close to uninformative. The line worth watching sequentially is underlying operating expenses, down 2.2% to $8,507m while underlying revenues rose 5.7%. That is 790 basis points of positive operating leverage in a single quarter, and unlike the tax rate it is a repeatable outcome of the cost programme.

Quality of Beat

• Revenue: Clean but unspectacular. Underlying revenues of $12,199m grew 4.5% year over year, and the mix improved: fee income up 10.5%, net interest income up 10.4% against a zero Swiss policy rate. The growth is organic, with no acquisitions and no disposal gains. Purchase-price-allocation accretion and other integration items added $701m to reported revenues, which is why reported revenue growth of 3.5% and underlying growth of 4.5% differ in sign of surprise. Nothing here is manufactured, but nothing here is a step-change either.
• Margins: Genuinely better, and overstated. The underlying cost/income ratio of 69.7% is the headline number, and it happens to sit just below the ratio UBS has told the market it intends to reach by the end of 2026. That coincidence should not be banked. The $668m of net litigation releases flows through operating expenses, and adding it back lifts underlying operating expenses to roughly $9,175m against $12,199m of underlying revenues, an underlying cost/income ratio near 75%. The genuine progress is the 790 basis points of sequential operating leverage and the $900m of incremental gross run-rate saves, not the 69.7% print.
• EPS: The weakest link in the chain. Of the $0.28 EPS beat, the two largest contributors are the litigation release and the tax rate, neither of which recurs. Management guided the fourth quarter's tax rate to normalize, producing a low-double-digit effective rate for the full year excluding any year-end deferred-tax-asset revaluation. The $0.76 print is therefore not a run-rate. A cleaner read on the quarter's true earnings power is the 12.7% return on CET1 capital excluding litigation, which management supplied unprompted, and which is a respectable but not exceptional number for a bank targeting substantially more.
• Capital: The most underrated positive in the release. The CET1 ratio rose 40 basis points sequentially to 14.8% and the CET1 leverage ratio to 4.6%, both comfortably above the roughly 14% and above-4% targets, while risk-weighted assets fell 2.8% year over year to $504.9bn. Total loss-absorbing capacity reached $199bn. Capital generation is not the constraint on this story; permission to return it is.

Segment Performance

UBS reports five business divisions, each an operating segment under IFRS, plus a Group Items residual. The table below shows underlying figures, which strip purchase-price-allocation accretion and integration-related expenses and are the basis on which management runs and discusses the divisions. Reported figures follow, because in this quarter the two tell materially different stories in two divisions.

Underlying Pre-Tax Profit by Division

Reported Pre-Tax Profit by Division

Read the two tables together. Personal & Corporate Banking is the trap: reported pre-tax profit fell 25.4% year over year, which looks like a Swiss franchise in retreat, while underlying pre-tax profit rose 8.7%. The gap is $376m of integration expense and purchase-price-allocation effects concentrated in the division that is bearing the operational brunt of the Swiss client migration. Anyone screening on reported divisional profit will misread the Swiss bank this quarter. The Investment Bank runs the other way, with reported profit above underlying because $219m of purchase-price-allocation accretion flows through its revenue line.

Global Wealth Management

GWM delivered $1,774m of underlying pre-tax profit, up 38.6% year over year, on underlying revenues of $6,410m (+7.3%). Excluding litigation effects, management put pre-tax profit at $1.6bn, up 21%, with all three major regions delivering double-digit profit growth. Asia Pacific was the standout, with pre-tax profit up 48% on 16 percentage points of positive operating leverage. The Americas grew pre-tax profit 26% and lifted the pre-tax margin to 13.4%, which remains the structural sore point of the franchise. A low-teens margin in the world's largest wealth pool is the gap to peers that management has repeatedly named as its key US priority.

The revenue mix was healthy on every line. Recurring net fee income grew 7% to $3.5bn on positive markets and more than $55bn of net new fee-generating assets over the trailing twelve months. Transaction-based income rose 11% to $1.3bn on structured products and cash equities. Net interest income of $1.6bn was up 3% year over year and 5% sequentially, helped by a mix shift toward transactional deposits and lower funding costs. Operating expenses were down 1%, or 2% adjusting for variable compensation, litigation and currency.

"GWM's invested assets increased by 4% sequentially to $4.7 trillion from favorable market conditions and strong asset flows. In the third quarter, we delivered net new assets of $38 billion, representing a 3.3% annualized growth rate. The quarterly performance was driven by exceptional inflows in Asia Pacific, which alone contributed $38 billion." — Todd Tuckner, Group CFO

That sentence contains the quarter's most important asterisk. Group net new assets of $38bn and APAC net new assets of $38bn are the same $38bn. EMEA added $6bn and Switzerland $3bn; the Americas lost $9bn. Management attributed the APAC number partly to "a small number of sizable flows linked to strategic holdings," which is disclosure language for concentrated, potentially non-repeating institutional-scale money, and partly to genuine post-integration momentum. Net new fee-generating assets, the harder and more valuable measure, were $9bn, with APAC and EMEA annualizing at 8% and 6% respectively.

Assessment: The engine is running, but it is running on one cylinder geographically. A 3.3% annualized net-new-asset rate is at the low end of what a franchise of this quality should produce, and it is only that high because of flows management itself flagged as lumpy. Until the Americas stops leaking, GWM's growth rate is an Asia story with a US drag attached, and Asia is the region where flow quality is hardest to underwrite.

Personal & Corporate Banking

P&C produced CHF 668m of pre-tax profit, up 1% year over year, or down 3% excluding litigation. In dollar underlying terms that is $833m, up 8.7%. The result was achieved with the Swiss policy rate at zero, a stronger Swiss franc, trade uncertainty weighing on corporate clients, and the division simultaneously carrying the most operationally intensive phase of the client migration. Net interest income fell 9% year over year but rose 1% sequentially in Swiss francs as lower funding costs and deposit-pricing measures offset the June rate cut. Recurring fee and transaction-based revenues rose 2% combined. Operating expenses fell 8%, or 6% excluding litigation.

Credit quality held. Credit loss expense of CHF 58m on an average loan portfolio of $248bn is a 9 basis point cost of risk, down 5 basis points sequentially, with CHF 56m of that in Stage 3 charges tied to a small number of corporate positions. Management guided fourth-quarter credit loss expense to around CHF 80m, citing global macro uncertainty reaching Switzerland.

Assessment: This is a resilient result dressed as a poor one by the reported numbers. The migration is consuming the division, the rate environment offers nothing, and it still grew underlying profit. The real question is what P&C looks like in 2027, when the migration expense is gone, the cost synergies land, and the division has a rebuilt Swiss deposit franchise operating at zero rates. The optionality is positive convexity on rates in either direction, which the CFO called out explicitly. The risk is that Swiss rates simply stay at zero and the synergies are all there is.

Investment Bank

The division that made the quarter. Underlying pre-tax profit of $787m more than doubled year over year on revenues of $3,025m, up 22.9%, with a 17% return on attributed equity. Both Global Banking and Global Markets posted their highest third-quarter revenues on record. Banking revenues of $844m rose 52%, with every region outpacing its fee pool and growing more than 40%. Advisory rose 47% on a record M&A quarter; Capital Markets rose 55% as leveraged capital markets fees nearly doubled and equity capital markets revenues grew roughly 1.5x on an IPO and convertible upswing. Global Markets revenues of $2.2bn rose 14% against a strong prior-year comparative, with equities up 15%, cash equities at a record on the franchise's best-ever market share, financing up 33% on record prime brokerage revenues and balances, and foreign exchange, rates and credit up 13%. Operating expenses rose 7%, driven by personnel.

"All I can do is recognize that our investment bank year-on-year has broadly flat balance sheet consumption. RWAs are broadly flat in the IB and yet they've driven revenue increases in — well into the double digits. So we continue to focus on our capital-light strategy and to execute appropriately." — Todd Tuckner, Group CFO

Management guided fourth-quarter banking activity to normalize from what it called Q3's exceptional levels, citing seasonality, transactions pulled forward into the third quarter, and the risk that a prolonged US government shutdown delays capital markets activity. Global Markets was likewise guided to more normalized transactional volumes against an unusually strong prior-year period inflated by activity ahead of the US administration transition.

Assessment: Doubling divisional profit on flat risk-weighted assets is the single most valuable data point in the release, because it is the proof-of-concept for the entire post-Credit-Suisse investment bank design. UBS is capturing wallet share without capital consumption, and the wealth-management partnership on structured solutions is a differentiator competitors cannot easily copy. The caution is that the fourth quarter was pre-guided down twice in the same paragraph, and a division that just printed a record is the one most likely to disappoint next quarter against its own comparison.

Asset Management

Underlying pre-tax profit of $282m rose 19% year over year, and 70% excluding net gains on disposals, on 5% higher revenues. Performance fees nearly doubled to $87m on strong hedge fund results. Net management fees were stable at $755m as higher balances and favourable currency offset the industry-wide shift into lower-margin products. Invested assets grew 5% sequentially and crossed $2 trillion for the first time. Net new money was $18bn, a 3.7% annualized growth rate, positive across every asset class, with $6bn in ETFs and $4bn in US separately managed accounts. Unified Global Alternatives took nearly $2bn of new client commitments plus $8bn from GWM clients, reaching $317bn of invested assets. Operating expenses fell 12%.

Assessment: The most improved division relative to expectations and the least discussed. A 3.7% organic growth rate with a 12% expense decline is a combination most listed asset managers cannot currently produce, and the integration here is substantially complete, so the operating leverage is real rather than promised. The offsetting facts are that net management fees were flat despite a 5% increase in assets, which is fee compression showing up exactly where it always does, and that the division owns the First Brands exposure and the pending O'Connor disposal.

Non-core and Legacy

NCL swung to a $102m underlying pre-tax profit from a $333m underlying loss a year ago, though the reported line remained a $102m loss. Revenues were negative $42m as roughly $100m of funding costs were partly offset by gains on position exits in securitized products and macro. Operating expenses were negative $149m, driven by $440m of net litigation releases; excluding litigation, expenses fell 56% year over year and 18% sequentially. Since the second quarter of 2023 the division has cut non-operational risk risk-weighted assets by almost 90%, including a further $2bn this quarter, freeing more than $7bn of capital for the Group. It has closed 94% of the 14,000 books it started with and decommissioned 65% of its IT applications, cutting its cost base by nearly 75%.

Assessment: The wind-down has been the most consistently under-appreciated element of the Credit Suisse deal, and it is close to done. But note what the positive pre-tax profit consists of: a $440m litigation release against negative revenues. NCL did not earn $102m; it released more provisions than it spent. The capital release is the durable value here, not the profit line, and roughly $7bn of freed capital is a real contribution to the CET1 ratio that made this quarter's 14.8% possible.

Key Group KPIs

Key Topics & Management Commentary

Overall Management Tone: Confident on execution and conspicuously non-committal on everything downstream of the Swiss regulator. Management spoke precisely and quantitatively about the integration, the cost programme and the divisions, then declined to size the 2026 buyback, the 2026 net-new-asset guidance, the divisional outlook and the capital requirement, deferring all four to the February results. The least convincing passages were the legal ones, where the answers were carefully lawyered and the same question was asked three separate times without the questioners appearing satisfied.

1. The Litigation Release That Made the Headline Number

The quarter's reported profit contains $668m of net litigation reserve releases, principally from completing obligations under Credit Suisse's residential mortgage-backed securities settlement with the US Department of Justice and resolving a legacy French cross-border matter. The CFO disclosed this in the second sentence of his prepared remarks rather than burying it, and volunteered the ex-litigation return figure unprompted.

"Included in our underlying performance are net litigation reserve releases of $668 million, primarily driven by the resolution of legal matters related to Credit Suisse's RMBS business and UBS' legacy cross-border case in France. Excluding litigation, our return on CET1 capital was 12.7% as we grew pretax profits by 26% across the group and by 19% in our core divisions." — Todd Tuckner, Group CFO

The disclosure is credible and appropriately prominent. What it also does is establish the correct denominator for every other metric in the release. A 16.3% underlying return on CET1 capital becomes 12.7%. A 69.7% underlying cost/income ratio becomes roughly 75% once the release is added back to the $8,507m underlying expense base. Both restated figures are still improvements year over year, and both sit meaningfully further from UBS's stated 2026 ambitions than the headline versions.

Assessment: Resolving the RMBS and France matters is unambiguously good news, and removing legal tail risk is worth more than the accounting release. But the release is a one-time balance-sheet event being reported inside an operating-performance narrative, and the quarter should be underwritten at 12.7%, not 16.3%.

2. The $10bn Cost Milestone, One Quarter Early

UBS delivered $900m of incremental gross run-rate cost saves in the quarter, taking the cumulative total to $10bn against an ambition of roughly $13bn by the end of 2026. That milestone was reached a quarter ahead of schedule. Against the 2022 baseline, the nominal cost base is down about 13%, or 24% excluding variable compensation, litigation and currency effects, and the conversion rate of gross to net saves is 77%.

The remaining $3bn was broken down when pressed. Technology will contribute a bit more than a third, close to 40%; headcount capacity a similar amount; the balance is third-party costs and real estate. Two-thirds of the benefit accrues to GWM and P&C, split two-to-one, with the remainder going to Non-core and Legacy and the other core businesses.

Assessment: This is the most trustworthy part of the story. Cost programmes are the one thing bank managements can actually control, and UBS has beaten its own schedule on a programme of unprecedented complexity. The 77% gross-to-net conversion is the number to track: it means roughly a quarter of each dollar saved is being reinvested or eaten by inflation, which is a normal and honest ratio.

3. The AT1 Ruling Reopens a Settled Question

On 13 October the Swiss Federal Administrative Court issued a partial ruling calling into question the legal basis for the write-off of Credit Suisse's AT1 instruments. UBS disclosed on the results day that it intends to appeal alongside FINMA. This dominated the Q&A: three separate analysts pressed it, one twice.

"It's in our interest to be a party in order to ensure that our perspective on the relevant facts relating to the acquisition is considered by the court as well, and this is important to safeguard the credibility of AT1 instruments for the key role that they play in bank recovery and resolution. Now being a party in the proceedings does not increase our potential legal exposure, but we do feel that it's important that we participate to bring to bear the best possible outcome." — Todd Tuckner, Group CFO

Pressed on what that assertion rests on, management confirmed it is acting on legal advice, that it does not believe a liability exists and therefore has taken no provision, that its belief is grounded in the view that the write-down complied with the instruments' contractual terms and applicable law and that FINMA's decree was lawful, and, notably, that UBS holds no indemnity from the Swiss government.

Assessment: The exposure is unprovisioned, unquantified and unindemnified, and the counterparty is a court rather than a negotiating table. The full principal of the written-down instruments is the theoretical ceiling on the question, even though nothing close to that is a realistic outcome. This is a tail risk that the market had discounted to near zero and that a single October ruling has re-priced to something greater than zero. That re-pricing, not the earnings, is what the stock traded on.

4. Swiss Capital Rules: The Overhang Management Cannot Resolve

UBS submitted its response to the Capital Adequacy Ordinance consultation at the end of the quarter and will respond to a second consultation, on capital requirements for foreign subsidiaries, before it closes in early January. The CEO's framing was procedural and deliberately unemotional, which is itself a change of register for a management team that has been publicly combative on this subject.

The practical consequence appeared in the capital guidance. The CFO told the market to expect the year-end 2025 CET1 ratio to fall sequentially, because it will absorb an accrual for intended 2026 buybacks plus the full-year 2025 dividend, and that the size of that accrual is contingent on, among other things, "visibility on the shape and timing of future capital requirements in Switzerland."

Assessment: The 2026 buyback is functionally a regulatory variable, not a management decision. Any model of UBS's 2026 and 2027 distributions is a model of Swiss politics wearing a spreadsheet. That is not a reason to avoid the stock permanently; it is a reason not to pay a re-rating multiple for it before February.

5. The Buyback Commitment, and Its Careful Hedging

The CEO intervened personally on capital returns, which he had largely left to the CFO elsewhere on the call.

"Our capital return policies and in particularly around share buyback will not be a stop and go policy. So as you heard from Todd, we're going to complete our current outstanding share buyback plan. And at year-end, all things being equal, we expect to accrue for share buyback to be executed during 2026. The size of the share buyback will be determined as we complete our process... But yes, we're going to have a share buyback in 2026, all things being equal." — Sergio Ermotti, Group CEO

For 2025 the picture is fully specified: $1.1bn of buybacks completed in the third quarter, up to $0.9bn planned in the fourth, reaching the $3bn full-year total, with continued accrual for a double-digit dividend increase. For 2026 the commitment is that a buyback will exist, twice qualified by "all things being equal."

Assessment: "There will be a buyback" is a meaningfully stronger statement than the market had a right to expect, and the explicit rejection of a stop-go policy is a real commitment from a CEO who does not make them lightly. It is also unsized, and size is the entire question. On the 3.26bn diluted share count implied by reported EPS, the $38.28 close puts the market capitalization near $125bn, so the difference between a $3bn and a $6bn programme is roughly 240 basis points of annual shareholder yield.

6. Global Wealth Management Americas: The Adviser Problem

The Americas lost $9bn of net new assets in the quarter, which management attributed directly to adviser movement following the structural changes introduced last year, including changes to the compensation grid. The defence offered was that the reset is working on profitability even as it costs assets: Americas pre-tax profit grew 26%, the pre-tax margin reached 13.4%, and management described the changes as pre-tax-margin accretive both to date and in its forward modelling.

On the timing question, management said it expects some lag effect into next year, that turnover is tapering, that the recruiting pipeline is healthy and that a record number of advisers are choosing to stay and retire at UBS. Asked directly for a time frame, it would not give one, deferring the division's 2026 net-new-asset guidance to the fourth-quarter results.

Assessment: Trading assets for margin is a defensible strategy in a business where the marginal adviser was unprofitable, and a 13.4% pre-tax margin is a genuine improvement on a chronically underperforming franchise. But the US is the largest wealth market on earth and UBS is shrinking in it. Two more quarters of outflows and the strategy stops looking like a reset and starts looking like a retreat.

7. The US National Bank Charter Application

UBS filed its application for a US national bank charter in the week of the results and expects approval in 2026. The strategic logic is the pre-tax margin gap in US wealth: the CFO has repeatedly identified expanding net interest income as a share of US revenues as the key lever to close it, and the charter would allow UBS to offer checking and savings accounts and an expanded lending shelf, putting its service suite on par with US peers.

Management was careful to deflate expectations of a step-change, describing the charter as "a natural add-on" and "part of an evolution" rather than transformational, noting the majority of its clients bank elsewhere and that moving them "is going to take time." The fourth consecutive quarter of US lending growth was cited as evidence the work is already underway.

Assessment: Structurally the right move and the correct diagnosis of the US problem. The honest framing of the timeline is creditable and also a warning: this is a 2027-and-beyond earnings contributor, not a 2026 one, and it does not offset the near-term adviser attrition.

8. Asia Pacific: A Record Quarter and a Concentration Question

APAC delivered $38bn of GWM net new assets on its own, GWM pre-tax profit in the region up 48% with 16 points of positive operating leverage, and the Investment Bank's best regional quarter on record. Invested assets across the asset-gathering businesses in APAC now exceed $1 trillion. Management attributed the strength to a constructive backdrop, engaged clients hedging and adding risk, China and China-technology allocations, continued US-asset demand, and post-integration momentum from teams now operating on one platform.

The forward framing was notably measured. Management called the quarter's performance "exceptional" while expecting the team to "continue to perform very well," and flagged that the region has been missing initial-public-offering monetization for two years, which it sees as upside rather than a run-rate.

Assessment: The APAC franchise is the clearest competitive advantage UBS owns and the strongest argument for a premium multiple. It is also the source of the quarter's flow concentration, and management's own language about "a small number of sizable flows linked to strategic holdings" invites the question of what the underlying run-rate is. We would underwrite APAC at well below $38bn a quarter.

9. Swiss Zero Rates and the NII Trajectory

Swiss policy rates sit at zero, and the CFO was blunt that P&C net interest income is stuck until they move. His framing of the asymmetry is worth recording, because it is the most useful forward statement on the call for a Swiss-domiciled bank: with positive convexity in the curve, rates moving in either direction help.

"From a P&C perspective, I think there, it's pretty clear that notwithstanding the point I made... around balance sheet management, the NII is going to be difficult to move out of this sort of flat trajectory with interest rates not having anywhere to go at this point. When they move, as I've said, given the positive convexity in the curve, whether rates move up or down, that will benefit us in P&C NII." — Todd Tuckner, Group CFO

For GWM, fourth-quarter net interest income was guided broadly stable sequentially, with modest lending growth offsetting lower-rate headwinds. Management noted that roughly half the balance sheet is already at very low rates given euro and Swiss franc exposure, that dollar rate cuts pressure deposit margins, and that lower rates also carry offsetting benefits through client releveraging and transactional activity, with net interest income only a quarter of GWM revenues.

Assessment: The zero-rate drag is real and the convexity argument is genuine rather than a deflection. Three consecutive quarters of client releveraging is the concrete evidence that the offset mechanism works. The uncomfortable implication is that the Swiss bank's earnings recovery from here is a cost story, not a revenue story, and cost stories have a finite runway.

10. First Brands and the Credit Question

UBS-managed funds carried roughly $500m of client exposure to the First Brands bankruptcy. Management stated UBS has no balance-sheet exposure, that only a small number of funds were affected, that the funds were targeted at sophisticated investors with clear risk disclosures, that no investment guidelines were breached, and that clients were informed swiftly. It confirmed the sale of the O'Connor hedge fund business to Cantor Fitzgerald continues toward a first close.

Asked more broadly about non-bank financial institution exposure and private credit, management said its NBFI counterparties are largely investment grade with strong collateral protection, that it sees no broader credit stress, and that the only credit theme it would call out is working through the Credit Suisse back book in Switzerland alongside trade-policy effects.

Assessment: The direct financial impact is immaterial and the disclosure was appropriately fast. The reputational mechanics are less easily dismissed: a wealth manager whose value proposition is judgment took a visible loss in client funds in the same quarter that a court reopened the AT1 write-off. Individually neither matters. Together they contributed to a tape that would not reward a 58% EPS beat.

11. The Integration Endgame and What Sunsets in 2026

More than 700,000 Swiss client accounts, over two-thirds of the total, have migrated to UBS platforms. Personal banking migration is substantially complete and corporate and institutional transfers have begun, with final migrations targeted for the end of the first quarter of 2026. Asset Management's integration is substantially complete. The Group is nearly halfway through application decommissioning, has shut 60% of legacy servers and processed around 40 petabytes of data. Integration costs are expected to be moderately lower in the fourth quarter and to taper further after completion, with a 2026 integration cost budget to be presented in February. Management also cited an employee survey showing sentiment among legacy UBS and legacy Credit Suisse colleagues now equally positive and above industry benchmarks.

Assessment: The end of integration expense is the single largest identifiable driver of reported earnings over the next two years, worth roughly $1.3bn a quarter at the current run-rate. The gap between the $2,828m reported and $3,590m underlying pre-tax profit is not permanent, and it closes on a schedule management has so far met early. This is the strongest argument for owning the stock, and it is the reason our rating is Hold rather than Underperform despite the regulatory overhang.

Guidance & Outlook

UBS does not guide to a group revenue or earnings number. What it gives is a set of directional statements by line and division, plus capital-return intentions. The table collects everything the company put on the record for the fourth quarter and beyond.

What the fourth quarter is being set up to look like: lower gross cost saves, higher Swiss credit losses, normalized investment banking in both halves of the division, flat net interest income in the two banking divisions, a sequentially lower CET1 ratio, and a normalized tax rate. Every single directional guide given for Q4 is neutral or negative. That is not pessimism from management so much as a deliberate reset of a comparison base after a quarter that benefited from a record investment banking print, a large litigation release and a 12% tax rate.

Where the Street sits: consensus had $12.68bn of revenue and $0.48 of EPS for the third quarter and got $12.76bn and $0.76. The revenue estimate was essentially right and the earnings estimate was wrong for reasons that do not repeat. Fourth-quarter estimates that simply roll forward the third quarter's tax rate and litigation contribution will be too high.

Guidance style: Specific and quantitative where the outcome is within management's control, such as cost saves, integration expense and credit loss expense. Deliberately unquantified where it is not, which this quarter means the entire 2026 capital-return and target framework. Management gave a directional Q4 guide on every division and refused a numerical 2026 guide on any of them.

Analyst Q&A Highlights

Why the 2026 Guidance Upgrade Is Being Held Back a Quarter

The call opened on the observation that UBS is visibly running ahead of its own plan, with Asset Management's cost/income ratio already at 66% against a sub-70% target and Non-core and Legacy ahead of its wind-down expectations, and the natural question of why the guidance is not being raised now. The answer was process-based rather than substantive: the year-end planning cycle has to conclude first, because it determines the 2026 integration budget, the incremental gross cost saves, and the divisional outlook on net interest income and Swiss credit losses.

Q: "It seems clear that UBS is already ahead of, I guess, the plan. Two examples, cost income in Asset Management, 66% against the plan of below 70% noncore delivering ahead of expectations. So why wait for Q4 before upgrading the guidance?"
— Giulia Miotto, Morgan Stanley

A: "You're asking why wait to update the guidance. Well, clearly, it's — as we go through our year-end planning process, which is ongoing and really critical for us, that will inform how we think about 2026 in terms of the things I mentioned in my prepared comments, for example, around integration budgets, also our gross run rate cost saves that we expect to generate, but also the outlook for each of the divisions, specifically around things like NII in our asset gathering businesses and credit loss expenses in our Swiss business."
— Todd Tuckner, Group CFO

Assessment: A procedurally reasonable answer that nonetheless leaves the stock without a catalyst for three months. Note what the reply implicitly concedes: the 2026 plan is not merely unannounced, it is unfinished, and two of its inputs are Swiss rates and Swiss credit, neither of which management controls. The deferral is genuine, not tactical.

Fund Losses in the First Brands Bankruptcy

The same opening turn raised the roughly $500m of client exposure to First Brands carried in UBS-managed funds, which had been extensively covered in the press but went unmentioned in the morning's release, along with whether it had triggered outflows or complicated the pending sale of the O'Connor hedge fund business. Management drew a firm line between balance-sheet exposure, of which there is none, and client fund exposure, which it characterized as limited to a small number of funds sold to sophisticated investors with clear risk disclosures and no breach of investment guidelines.

Q: "First Brands. I didn't see any comment this morning, but there has been extensive press coverage about the $500 million hit on the asset management client asset side. So could you please have your comments on this issue? Have you seen outflows on the back of it? Is this impacting your sale of O'Connor?"
— Giulia Miotto, Morgan Stanley

A: "UBS does not have balance sheet exposure to First Brands and only a small number of funds are effective. Obviously, it's always unfortunate when clients generate losses. That said, it's important to note that the most affected funds were targeted at sophisticated investors and had clear risk disclosures. No investment guidelines were breached... As previously announced, we continue to progress with the sale of the O'Connor hedge fund business to Cantor Fitzgerald, and we're working closely together towards a first close."
— Todd Tuckner, Group CFO

Assessment: The financial answer is complete and the exposure is immaterial to the Group. The question about outflows was not answered. Asset Management reported $18bn of net new money in the quarter, so any effect is not visible at the divisional level, but the omission was conspicuous in a reply that was otherwise thorough.

The Legal Basis for the AT1 Write-Off, Asked Three Ways

The dominant topic of the call, raised in three separate turns by different questioners, was whether UBS carries exposure from the reopened AT1 matter. The line of questioning worked through it in stages: whether the write-down and the acquisition were one transaction or two sequential steps; on what basis management asserts no liability; whether a government indemnity exists; and, in a clarification that management confirmed flatly, whether Credit Suisse had any AT1 instruments outstanding at the point of acquisition. Management's position is that the write-down was an integral part of the rescue package rather than a separable precondition, that no liability exists and therefore no provision has been taken, and that it holds no indemnity.

Q: "You said what you also said in the FAQ document that being a party in the proceedings does not increase our potential legal liability. And in our view, there should be no liability in this matter. On which basis are you exactly saying that, I mean, you are a party of this process, isn't it? Do you actually have an indemnity by the government to compensate for any damages that may arise out of this case?"
— Multiple analysts incl. Stefan Stalmann, Autonomous; Kian Abouhossein, JPMorgan; Joseph Dickerson, Jefferies

A: "In terms of on which basis we've made the conclusions, we're acting on legal advice naturally. Of course, as an accounting matter can say that we don't believe there is a liability and therefore, if there's no liabilities, there's no basis to provide. And our belief is based on the fact that we believe the write-down was in accordance with the contractual terms of the AT1 instruments and the applicable law and that FINMA's decree was lawful. So that was the basis of our conclusion. And no, we don't have an indemnity from the Swiss government."
— Todd Tuckner, Group CFO

Assessment: The most consequential exchange on the call. Three things are now on the record that were not before: no provision, no indemnity, and a legal argument resting on the write-down being inseparable from the rescue package. That third point is the load-bearing one, and it is precisely what the court's partial ruling put in question. Management answered every question asked and the answers do not close the issue, because the issue is not within its power to close.

Mechanics of the 2026 Buyback Accrual

Two separate turns pressed on how the year-end capital accrual will actually work and whether a second buyback tranche could be announced mid-2026 once regulatory clarity improves. Management confirmed the accrual will capture whatever 2026 repurchase amount UBS commits to or intends at year-end, consistent with the Swiss capital adequacy ordinance, alongside the full-year 2025 dividend. The CEO then intervened to make the commitment explicit and to rule out a stop-start approach.

Q: "I guess previously, you said when you published your opinion paper that with full year results, you don't expect full visibility on the regulation. I guess nothing has really changed on that aspect. And then I guess, would you be able to sort of like announce another buyback in the course of the year once you have more clarity? Or would that be basically excluded by your sort of like approach to buybacks in 2026?"
— Anke Reingen, RBC

A: "Let me maybe remind what I mentioned in the last few quarters as we were answering the question on capital returns that our capital return policies and in particularly around share buyback will not be a stop and go policy... And at year-end, all things being equal, we expect to accrue for share buyback to be executed during 2026. The size of the share buyback will be determined as we complete our process and as we have more visibility both on how the integration is progressing and also on any potential developments on the capital requirements topic in Switzerland. But yes, we're going to have a share buyback in 2026, all things being equal."
— Sergio Ermotti, Group CEO

Assessment: The CEO taking this question himself was the signal. Committing to a 2026 buyback before knowing the capital rules is a deliberate act of reassurance, and the rejection of stop-go policy is the closest thing to a distribution framework UBS has offered. The size remains the variable, and the question of a mid-year top-up was not directly answered.

The Composition of the Remaining $3bn of Cost Saves

A question on whether the technology decommissioning that follows the Swiss migration had ever been quantified produced the most useful new disclosure of the call: a full breakdown of the residual gross cost saves by driver and by division, which had not previously been given at this granularity.

Q: "You're obviously well advanced on the client migration in Switzerland. This is supposed to lead to the IT decommissioning next year and the cost/income ratio boost. Did you ever provide actually a number, an absolute number in dollar billion of how much of a boost this would be to your cost base?"
— Flora Bocahut, Barclays

A: "We have $3 billion that we expect to convert to a significant part to net saves over the course of 2026 and drive to our underlying cost-income ratio target by the end of 2026... my expectation, as I look out over the last five quarters is that technology will make up a bit more than 1/3, let's say, close to 40% of the gross run rate cost saves of that residual $3 billion. And headcount capacity is sort of a similar level with the balance being third party and third-party costs in real estate. And from a divisional perspective, I expect 2/3 of that benefit to inure to Global Wealth Management and P&C, split 2/3, 1/3 with the balance inuring to noncore and the other core businesses."
— Todd Tuckner, Group CFO

Assessment: This is the most modellable answer given on the call. It converts a headline ambition into a division-level bridge: roughly $2bn of the residual $3bn lands in GWM and P&C, split about $1.3bn and $0.7bn. Applied to the Swiss bank, that is a material fraction of a division running at roughly $3bn a year of underlying pre-tax profit, and it is the arithmetic behind our view that P&C's 2027 earnings look nothing like its 2025 reported earnings.

Durability of the Asia Pacific Flow Surge

A questioner characterized the APAC flows as apparently a mix of one-off and underlying improvement and asked which it was. Management confirmed both elements, describing a constructive backdrop with engaged clients hedging downside and adding China and China-technology exposure alongside continued US allocations, plus genuine post-integration momentum from teams now on a single platform. It then flagged initial public offering monetization as a source of upside that has been absent for two years.

Q: "First question on Asia, phenomenal flows in the quarter. And it sounded like it was a bit of a mix of slightly one-off but also slightly underlying pickup. I just wondered if you could expand on that. Is this something that you expect to see sustained strength? Is this the beginning of a trend of improving flows from Asia?"
— Jeremy Sigee, BNP Paribas

A: "So while the performance in the quarter was exceptional, my expectation for the team is that they remain engaged with clients, and we continue to perform very well in the region. I would also call out, as I've said in the past, that what we were missing a little bit over the last couple of years from a macro perspective was monetization coming from ECM type activities, particularly IPOs. We know that the region is quite hot at the moment, and that portends upside for us as we go forward in terms of flows in APAC."
— Todd Tuckner, Group CFO

Assessment: The answer is honest and it is also a soft warning. "Exceptional" is management's own word for the quarter, and the forward statement is that the team will "perform very well," not that the flow rate persists. Anyone annualizing $38bn of APAC net new assets is extrapolating a number the company has pointedly declined to extrapolate.

US Adviser Attrition and What the National Charter Changes

A two-part question on the strategic benefit of the US national bank charter and the net-new-asset outlook after the Americas outflows drew the clearest statement of the US strategy on the call, and a refusal on timing. A follow-up asking specifically whether adviser turnover flattens in the first or second half of 2026 was declined, with the answer deferred to the fourth-quarter guidance.

Q: "Wealth Management Americas. You applied for the National Charter. Can you talk about the benefits of the charter and also talk about net new asset outlook post the outflows in the third quarter that we saw in NA and adviser attrition going forward, how we should think about that?"
— Kian Abouhossein, JPMorgan

A: "Expanding NII as a percentage of revenues in the U.S. business is one of our key strategic priorities to narrow the pretax margin gap to peers. We think the National Charter once we receive it, will enable us to serve our clients on a more comprehensive basis... In terms of the NNA outlook for the U.S., ... the changes that we introduced last year, including vis-a-vis the compensation framework has led to some near-term adviser movement, but importantly, is lifting pretax margins and most importantly, enabling us to reinvest in the platform to help advisers grow their books and better serve clients. Looking ahead, while I do expect some lag effect from the movement that we've seen into next year, we do see turnover tapering, and that's supported by a healthy recruiting pipeline."
— Todd Tuckner, Group CFO

Assessment: The diagnosis is right and the remedy is slow. Two things were conceded here that matter for 2026 modelling: outflows continue into next year on a lag, and the charter's benefit is evolutionary. The refusal to timestamp the turnover inflection, even when pressed for nothing more precise than a half-year, suggests management does not yet know.

Non-Bank Financial Institution and Private Credit Exposure

With First Brands in the background and broader market anxiety about private credit, a question probed the Group's exposure to non-deposit-taking financial institutions, private credit, private equity and hedge funds, and asked for a general view on credit conditions. Management's answer was unqualified in a way that little else on the call was.

Q: "Asset quality remains rock solid. At least in the U.S. disclosure, we see that your exposure to nondeposit-taking financial institutions is quite low, but any additional details of exposure to private credit, private equity and hedge funds would be appreciated and potentially also broader thoughts on the credit concerns in the market outside of single cases."
— Benjamin Goy, Deutsche Bank

A: "Our NBFI counterparties are largely investment grade, strong protection in terms of collateralized positions. So I have no concerns about the broader credit environment impacting on UBS at this stage. I'm seeing nothing that would suggest any issues beyond what I report regularly on, which is in our Swiss environment, just working through the back book from the Credit Suisse acquisition... and see no broader stress in the credit market that I would, particularly in the private credit market, that I would call out."
— Todd Tuckner, Group CFO

Assessment: The balance-sheet evidence supports the confidence. Loans of $666bn are roughly 92% collateral-secured, mortgages are 58% of the book at about 50% average loan-to-value, Lombard lending is a further 24%, credit-impaired exposures are stable at 90 basis points and the cost of risk fell 4 basis points. This is a genuinely low-risk lending book, and the credit question is not where this investment case will be decided.

What They're NOT Saying

1. Any 2026 number at all. No revenue guide, no cost guide, no net-new-asset guide, no integration budget, no buyback size, no updated divisional targets. Management deferred every forward-looking quantity to February. For a company this far into a plan and running ahead of it, that is an unusually complete blackout, and it is downstream of the capital rules rather than of the business.
2. The size of the Swiss capital requirement. UBS has submitted consultation responses and framed the process procedurally, but attached no number to the outcome and gave no scenario range. The market is left to price a distribution of regulatory outcomes with no management-supplied anchor.
3. Any quantification of AT1 tail risk. No provision has been taken and no exposure range was offered. Management's position is that no liability exists, so no sizing is warranted. That is internally consistent and it means the disclosure carries no number a modeller can use.
4. When US adviser attrition stops. Asked directly for a time frame, and again in a follow-up narrowed to first half versus second half of 2026, management would say only that turnover is "tapering" and deferred the guidance. The lag effect into 2026 was conceded; its magnitude was not.
5. The underlying APAC flow run-rate. The $38bn included "a small number of sizable flows linked to strategic holdings," a phrase deployed twice without quantification. Without that number the region's organic growth rate cannot be separated from the lumpy component.
6. Whether First Brands triggered client outflows. The question was asked explicitly and the answer covered balance-sheet exposure, fund suitability, disclosures, guidelines and the O'Connor timeline, but not outflows.
7. A US wealth pre-tax margin target or timeline. Management has named the margin gap to peers as the strategic problem and the charter as part of the solution, but has never put a target margin or a date on closing it. A 13.4% margin was presented as progress without a destination.
8. Whether a mid-2026 supplementary buyback is possible. Asked directly whether a second tranche could be announced once regulatory clarity improves, the answer addressed the year-end accrual mechanic and the no-stop-go principle but never addressed the mid-year top-up.

Market Reaction

• Pre-print setup: The ADR closed at $39.09 on 28 October, up 28.9% year to date against 17.2% for the S&P 500, up 19.1% over the trailing twelve months, but down 5.4% over the trailing thirty days. The 52-week closing range entering the print was $26.12 to $42.38, so the stock arrived roughly 7.8% below its 52-week closing high after a soft month.
• Reaction session: UBS reports at 06:45 Central European Time, before the US open, so the print day is the reaction day. The ADR gapped down, opening at $38.58 (-1.3%), traded a $38.12 to $38.87 range, and closed at $38.28, down 2.1% or $0.81. The S&P 500 was unchanged on the session, so the entire move is stock-specific.
• Volume: 2.9m shares against a 1.7m thirty-day average, or 1.7x normal. Elevated but not extreme, consistent with repositioning rather than capitulation.
• Primary listing divergence: The Zurich line traded higher in the opening minutes on the headline beat before giving the gain back. The New York ADR never traded green on the session.
• Position versus range: The close leaves the ADR 9.7% below the 52-week closing high and still 46.6% above the 52-week closing low.

A 58% EPS beat that closes down 2.1% is a market telling you it has already discounted the operating performance and is trading something else. Three things arrived in the same window and all of them point at the denominator rather than the numerator: the 13 October court ruling reopening the AT1 write-off, disclosed alongside UBS's intention to appeal; an open Swiss capital consultation with a second tranche running to early January; and a visible, if immaterial, client loss in the First Brands bankruptcy. None of the three affects 2025 earnings. All three affect the capital that determines what shareholders receive from those earnings.

The composition of the beat did the rest. When roughly a quarter of reported pre-tax profit is a legal-provision release and the tax rate is half its normal level, a large headline beat converts into very little estimate revision. Sell-side models for the fourth quarter had already been cutting buyback assumptions on the Swiss proposals well before this print. This quarter gave them no reason to reverse, because management explicitly declined to size the 2026 programme. A beat with no forward-estimate consequence and a new legal overhang is a fade, and that is what the tape delivered.

Street Perspective

Debate: Is the Swiss Capital Overhang Priced In?

Bull view: The stock has been de-rated for the better part of a year on this specific fear, sell-side buyback assumptions have already been cut substantially, and the consultation process has a defined end. Once the ordinance is settled, even at a punitive level, the uncertainty discount collapses and the stock re-rates on the certainty alone. Meanwhile the bank keeps compounding capital at 14.8% CET1 with risk-weighted assets falling.

Bear view: The proposals under consultation contemplate capital requirements large enough to consume years of distributable earnings, and the process now runs into 2026 with a second consultation on foreign-subsidiary capital closing in January. A settled bad outcome is not a catalyst; it is a permanently lower distribution. Management's refusal to size the 2026 buyback tells you it does not know either.

Our take: The bear case is better argued on the facts available today. The bull case requires believing the political outcome lands nearer the industry's position than the regulator's opening one, and there is no evidence for that yet. The relevant asymmetry is that resolution in February is a genuine binary, and buying ahead of a binary you cannot handicap is speculation rather than investment. This is the single largest reason our rating is Hold.

Debate: Is the Underlying Earnings Power Real, or a Litigation Mirage?

Bull view: Look through the release. The Investment Bank doubled underlying profit on flat risk-weighted assets, Asset Management grew organically at 3.7% while cutting costs 12%, GWM grew underlying revenue 7% with fee income up 10.5%, and underlying operating expenses fell 2.2% sequentially while underlying revenue rose 5.7%. That is 790 basis points of clean operating leverage in a single quarter, and $3bn of further gross saves is still to come.

Bear view: Strip the release and the return on CET1 capital is 12.7% and the underlying cost/income ratio is roughly 75%, both a long way from the ambitions the stock is being valued against. The record Investment Bank quarter has been pre-guided down for the fourth quarter, Swiss net interest income is stuck at zero rates, the Americas is losing assets, and the fourth-quarter guide is negative on every single line.

Our take: Both are right about different time horizons. The 12.7% ex-litigation return is the honest read on today, and it is unexceptional. The bull case is not about today: it is that roughly $1.3bn a quarter of integration expense stops in 2026 and $3bn of gross saves converts largely to net. That is a large, identifiable, scheduled earnings uplift with a management team that has so far hit its milestones early. We are on the bull side of the 2027 argument and the bear side of the 2026 one.

Debate: Can the US Wealth Franchise Actually Be Fixed?

Bull view: The compensation-grid reset is working exactly as designed. Americas pre-tax profit grew 26% and the margin reached 13.4% while shedding the least productive advisers. The national bank charter arrives in 2026 and unlocks the deposit and lending economics that explain most of the margin gap to US peers. Four consecutive quarters of US lending growth show the strategy is already in motion.

Bear view: A 13.4% pre-tax margin remains roughly half what the best US wealth platforms earn, the franchise lost $9bn of assets in a single quarter, management will not say when that stops, and it has conceded the outflows continue into 2026 on a lag. The charter was described by management itself as evolutionary rather than transformational. Shrinking in the world's largest wealth market is not a strategy.

Our take: The margin improvement is real and the direction is correct, but the market is being asked to fund a multi-year rebuild with no target margin, no date, and no net-new-asset guidance. We treat US wealth as a genuine call option with an uncertain strike rather than as a component of the base case. It is not a reason to sell the stock; it is a reason not to pay up for it.

Model Update & Valuation Framework

This is initiating coverage, so the table below sets our starting assumptions rather than revising prior ones. The organizing principle is that reported and underlying earnings converge over 2026 and 2027 as integration expense sunsets, and that the distribution of that convergence to shareholders is the variable the Swiss regulator controls.

Valuation. At the $38.28 close the ADR trades at 1.44x the $26.54 tangible book value per share reported for the quarter. Tangible book grew 2% sequentially, net of buybacks. Rolling that forward at a similar pace through 2026 puts tangible book per share near $28.70 a year out, and our 12-month target of $40 applies a multiple of just under 1.40x to that figure. From the $38.28 spot that implies +4.5%, which is a market-like return and precisely why the rating is Hold rather than Outperform.

What moves the target. The multiple, not the book value, is where the range lives. A benign Swiss capital outcome in February plus a 2026 buyback at or above $4bn would justify 1.6x or better, taking the target toward $46. A punitive ordinance that caps distributions, or an adverse turn in the AT1 appeal, would argue for 1.15x to 1.20x and a target in the low $30s. The earnings path between those two scenarios barely differs. That is an unusual and uncomfortable property for a bank of this quality, and it is the reason we are content to wait for February rather than pre-position.

Thesis Scorecard: Establishing Coverage

No prior Aardvark Labs coverage of UBS exists, so this quarter establishes the pillars rather than grading them. The statuses below are our opening assessments as of this print, and each subsequent quarterly recap will score against these same pillars rather than inventing new ones.

Overall: The operating thesis is stronger than the equity thesis. Three of four bull pillars are confirmed or partly confirmed on this print, and the cost programme is running ahead of a schedule management set itself. The equity thesis is nonetheless gated by two bear pillars that no amount of execution addresses, because both sit with the Swiss state rather than with UBS.

Action: Hold. Own the franchise after February, when the capital plan and the 2026 targets are published, rather than paying today for the option that the ordinance is benign. We would move to Outperform on either a Swiss capital outcome at or better than the industry's proposals, or a 2026 buyback announced at $4bn or more; and to Underperform on a materially adverse ordinance, an adverse turn in the AT1 appeal that forces a provision, or a third consecutive quarter of Americas net-new-asset outflows.